4-Chloro-3-(2-(2-((4-((3S,5R)-3,5-dimethylpiperazin-1-yl)phenyl)amino)pyrimidin-5-yl)ethyl)-5-methoxy-N-methylbenzamide) is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups such as a chloro group, a methoxy group, and a piperazine moiety. This compound features a benzamide backbone, which is often associated with biological activity, particularly in medicinal chemistry. The presence of the piperazine ring suggests potential interactions with biological targets, making it a candidate for pharmaceutical applications. The compound's molecular weight and solubility characteristics would influence its bioavailability and pharmacokinetics. Additionally, the stereochemistry indicated by the (3S,5R) configuration of the piperazine ring may play a crucial role in its biological activity and receptor interactions. Overall, this compound exemplifies the complexity often found in drug design, where structural modifications can significantly impact efficacy and safety profiles.

4-chloro-3-(2-(2-((4-((3S,5R)-3,5-dimethylpiperazin-1-yl)phenyl)amino)pyrimidin-5-yl)ethyl)-5-methoxy-N-methylbenzamide

1628537-44-9: 4-Chloro-3-(2-(2-((4-((3S,5R)-3,5-dimethylpiperazin-1-yl)phenyl)amino)pyrimidin-5-yl)ethyl)-5-methoxy-N-methylbenzamide) is a complex organic compound characterized by its intricate molecular structure, which includes multiple functional groups such as a chloro group, a methoxy group, and a piperazine moiety. This compound features a benzamide backbone, which is often associated with biological activity, particularly in medicinal chemistry. The presence of the piperazine ring suggests potential interactions with biological targets, making it a candidate for pharmaceutical applications. The compound's molecular weight and solubility characteristics would influence its bioavailability and pharmacokinetics. Additionally, the stereochemistry indicated by the (3S,5R) configuration of the piperazine ring may play a crucial role in its biological activity and receptor interactions. Overall, this compound exemplifies the complexity often found in drug design, where structural modifications can significantly impact efficacy and safety profiles.

<p>Fanregratinib is a fibroblast growth factor receptor (FGFR) tyrosine kinase inhibitor.</p>

CAS 1628537-44-9

4-chloro-3-(2-(2-((4-((3S,5R)-3,5-dimethylpiperazin-1-yl)phenyl)amino)pyrimidin-5-yl)ethyl)-5-methoxy-N-methylbenzamide

Fanregratinib

Ref: TM-T201139